Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1023670Generated: October 31, 2026

1-Pentanol → Potassium 4-[{[(4-fluorophenyl)methyl]imino}(hydroxy)methyl]-1-methyl-2-{2-[(5-methyl-1,3,4-oxadiazole-2-carbonyl)amino]propan-2-yl}-6-oxo-1,6-dihydropyrimidin-5-olate

https://huagongshe.com/reaction/1023670

Reaction equation

Participants

RoleNameHCIDCharge
Reactant1-PentanolHCID 6276—
ReactantPotassium HydroxideHCID 14797—
ReactantRaltegravirHCID 54671008—
ProductPotassium 4-[{[(4-fluorophenyl)methyl]imino}(hydroxy)methyl]-1-methyl-2-{2-[(5-methyl-1,3,4-oxadiazole-2-carbonyl)amino]propan-2-yl}-6-oxo-1,6-dihydropyrimidin-5-olateHCID 23668479—

Reaction Steps

A vial (20 ml) was charged with Raltegravir free hydroxy (0.25 g) and pentanol (2 mL) to form a solution. KOH 85% (38 mg) was added at room temperature, forming a solution. This solution was stirred for 3 hours. The product precipitated and was isolated by centrifuge filtration. The isolated product was dried in a vacuum oven at 40° C. for 5 h to obtain Raltegravir potassium crystalline Form XIII.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS08722722B2
Source datasetuspto-grants-2014_05
ORD IDord-7a898067033e4dd2ab09f7d6c634bc4a
Source noteuspto-grants-2014_05